Handel nachbörslich: 5.37 0.17 +3.27%

Nls Pharmaceutics Ltd (NLSP)

Nls Pharmaceutics Ltd Aktie (NLSP) Neueste Nachrichten

Nls Pharmaceutics Ltd (NLSP)

Nls Pharmaceutics Ltd Aktie (NLSP) Neueste Nachrichten

NLS Pharmaceutics announces 1-for-40 reverse stock split - Investing.com

NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split - AccessWire

NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split - Yahoo Finance

A year in review: NLS Pharmaceutics Ltd (NLSP)’s performance in the last year - US Post News

Market Highlights: NLS Pharmaceutics Ltd (NLSP) Ends on a Low Note at 0.14 - The Dwinnex

NLSP: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

NLS Pharmaceutics Shareholders Approve Key Measures - TipRanks

NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split - StockTitan

NLS Pharmaceutics Adjusts Warrants Terms - TipRanks

NLS Pharmaceutics Plans Capital Increase and Debt Restructuring - TipRanks

Investor’s Toolkit: Key Ratios for Assessing NLS Pharmaceutics Ltd (NLSP)’s Performance - The Dwinnex

What was NLS Pharmaceutics Ltd (NLSP)’s performance in the last session? - US Post News

NLSP’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Market Update: NLS Pharmaceutics Ltd (NLSP) Sees Negative Movement, Closing at 0.16 - The Dwinnex

NLS Pharmaceutics Prepares for Share Consolidation - TipRanks

A stock that deserves closer examination: NLS Pharmaceutics Ltd (NLSP) - US Post News

NLS Pharmaceutics (NASDAQ:NLSP) Trading 4.3% Higher - Defense World

NLS Pharmaceutics Gains PwC’s Endorsement - TipRanks

NLS Pharmaceutics to Merge with Cell Therapy Developer Kadimastem - Sleep Review

NLS Pharmaceutics Announces CFO Departure Amidst Merger Plans - TipRanks

It is Poised to be a Bull Market for NLS Pharmaceutics Ltd (NLSP) - SETE News

NLS Pharmaceutics Ltd (NLSP) stock analysis: A simple moving average approach - US Post News

Views of Wall Street’s Leading Experts on NLS Pharmaceutics Ltd - SETE News

Quarterly Snapshot: Quick and Current Ratios for NLS Pharmaceutics Ltd (NLSP) - The Dwinnex

Daily Market Movement: NLS Pharmaceutics Ltd (NLSP) Sees a -9.34 Decrease, Closing at 0.22 - The Dwinnex

NLS Pharmaceutics Ltd [NLSP] Stock trading around $0.23 per share: What’s Next? - The DBT News

NLS Pharmaceutics to merge with Kadimastem in stock deal By Investing.com - Investing.com Nigeria

NLS Pharmaceutics to merge with Kadimastem in stock deal - Investing.com India

NLSP’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

NLSP Stock: NLS Pharmaceutics A Beacon of Hope in CNS Disorder Treatment - All Finance Times

NLS Pharmaceutics to merge with Kadimastem in stock deal - Investing.com

NLS Pharmaceutics to Absorb Kadimastem as Subsidiary After Agreeing to Merger - MarketWatch

NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge - AccessWire

NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge - StockTitan

Kadimastem Ltd signed a letter of intent to acquire NLS Pharmaceutics AG in a reverse merger transaction. - Marketscreener.com

NLS Pharmaceutics Ltd (NLSP) Stock: A Year of Highs and Lows - The InvestChronicle

Market Insights: NLS Pharmaceutics Ltd (NLSP)’s Notable Gain of 4.76, Closing at 0.22 - The Dwinnex

NLS Pharmaceutics Ltd: Weathering Stock Market Storms with 10.25M Market Cap - The InvestChronicle

NLS Pharmaceutics Ltd (NLSP)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Rises By 2,335.2% - Defense World

NLS Pharmaceutics Ltd (NLSP) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

NLS Pharmaceutics Ltd (NLSP)’s Day in Review: Closing at 0.19, Down by -6.34 - The Dwinnex

NLS Pharmaceutics (NASDAQ:NLSP) Shares Down 6.3% - Defense World

Deeper Dive: Understanding NLS Pharmaceutics Ltd (NLSP) Through its Various Ratios - The Dwinnex

NLS Pharmaceutics Ltd (NLSP) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

Was anything negative for NLS Pharmaceutics Ltd (NLSP) stock last session? – US Post News - US Post News

NLS Pharmaceutics Unveils New Share Purchase Warrant - TipRanks

Form 424B5 NLS Pharmaceutics Ltd. - StreetInsider.com

NLS Pharmaceutics Ltd [NLSP] moved up 31.43: Why It’s Important - The DBT News

Tamboran Resources director buys $158,400 in company stock By Investing.com - Investing.com

Allied gaming executive Choi buys shares worth $778k By Investing.com - Investing.com UK

NLS Pharmaceutics shares are trading lower after the company announced a registered direct offering of 3,277,750 ... - Quantisnow

NLS Pharmaceutics Annnounced Registered Direct Offering Of 3,277,750 Shares At $0.24/Share - Quantisnow

NLS Pharmaceutics Announces Registered Direct Offering - AccessWire

NLS Pharmaceutics Announces Registered Direct Offering | NLSP Stock News - StockTitan

Investing in Penny Stocks With $1k, What to Know - PennyStocks

NLS Pharmaceutics reports preclinical results from in vitro studies targeting α-synuclein for Parkinson’s disease - BioWorld Online

NLS Pharmaceutics reports progress in Parkinson's treatment By Investing.com - Investing.com

NLS Pharmaceutics’ Breakthrough in Parkinson’s Research - TipRanks

SharkNinja shares target raised by BofA on product strategy By Investing.com - Investing.com

Scotiabank sets Sector Outperform rating on Exact Sciences shares By Investing.com - Investing.com

Nuscale Power shares target raised on technology benefits, rated Buy By Investing.com - Investing.com

NLS Pharmaceutics reveals potential Parkinson's treatment By Investing.com - Investing.com

NLS Pharmaceutics reveals potential Parkinson's treatment By Investing.com - Investing.com Australia

Ähnlich wie NLSP